Navigation Links
Affymetrix Reports Second Quarter 2009 Results
Date:7/22/2009

ces on which any such statements are based.

PLEASE NOTE:

Affymetrix, the Affymetrix logo, GeneChip, and all other trademarks are the property of Affymetrix, Inc.

- Financial Charts to Follow -

                                AFFYMETRIX, INC.
                       CONDENSED CONSOLIDATED BALANCE SHEETS
                                (IN THOUSANDS)
                                 (UNAUDITED)

                                        June 30,     December 31,
                                         2009           2008
                                         ----           ----
                                                      (Note 1)
     ASSETS:
     Current assets:
      Cash and cash equivalents         $73,267       $113,292
      Restricted cash - short-term
       portion                            1,182          4,402
      Available-for-sale securities -
       short-term portion               208,075        250,970
      Accounts receivable, net           57,108         62,726
      Inventories                        51,803         51,333
      Deferred tax assets -
       current portion                    1,649          1,077
      Prepaid expenses and
       other current assets               9,155         15,725
                                          -----         ------
           Total current assets         402,239        499,525
                                        -------        -------
     Available-for-sale
      securities - long-term
      portion                            68,277         26,900
     Property and equipment, net         74,107         89,345
     Acquired technology rights, net     55,714         62,569
     Deferred tax assets -
      long-term portion                   4,269          4,764
     Restricted cash -
      long-term portion                   2,359          2,175
    
'/>"/>
SOURCE  Affymetrix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 

Related medicine news :

1. Biolytix to Offer Industrial Gene Expression Analysis and Genotyping Services Using Affymetrix GeneChip(R) Technology
2. IPA Now Supports Affymetrix Exon Arrays and Additional Species
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CHICAGO, Dec. 16 Allscripts (Nasdaq: ... its financial results for the three and six ... market opens on Monday, January 11, 2010. Allscripts ... to discuss the company,s earnings and other information ... morning. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, ...
(Date:12/16/2009)... HealthSciences Institute will sponsor a new learning ... organizations who serve individuals at risk of, ... health plan, medical home and other provider ... noncommercial webinars on topics, solutions and case ... care improvement. Each webinar will include a ...
(Date:12/16/2009)... Institute announce the first comprehensive analyses of cancer genomes. ... the DNA of cancer cells which are acquired during ... and a lung cancer, reveal for the first time ... cancers. , Lung cancer causes around one million deaths ... The number of mutations found suggest that a typical ...
(Date:12/16/2009)... Planet-Friendly Organics, Solar-Powered Manufacturing and Sustainable Packaging at an Affordable ... ... Angeles, CA (PRWEB) December 16, 2009 -- Actively healthy families ... all natural skin care for their children as Episencial ... featuring the beloved artwork of The Very Hungry Caterpillar from ...
(Date:12/16/2009)... leader of Digital Pen and Paper technology and the provider ... today announced that it is ranked among the Fastest Growing ... 2009. , ... (PRWEB) December 16, ... for the capture, digitalization and management of handwritten data. Kayentis ...
Breaking Medicine News(10 mins):Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2
... March 13 In a continued effort to ... result in optimized revenue and safer care, Surgical ... of integrating their SIS Solution to Pyxis Supply ... )In a time of economic uncertainty, it ...
... study conducted with 21 pens of cattle in ... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, ... results of a large-scale commercial beef feedlot study ... Econiche(TM) - have been published in this month,s ...
... From Preventable Medical Errors , ... San Francisco, CA ... Safety Awareness Week , Quantros , a leading provider of ... an educational video that exposes the staggering numbers of Americans who ...
... Dr. Paul Cirangle, the most experienced bariatric surgeon in the state of ... practices on the outer islands, Dr. Cirangle,s weight loss surgery patients will ... ... Hilo, HI (PRWEB) March 13, 2009 -- As America,s fight with obesity ...
... Center for Refugee Health and Human Rights (BCRHHR) ... the large number of Tibetan refugee monks who ... Boston suffering from symptoms of traumatic stress, interfering ... by their traditional healers as having srog-rLung, a ...
... Arthritis and joint pain can severely limit the movement of your pet, ... PetCareRx is leading the industry in supplying the best medications to ... ... 12, 2009 -- PetCareRx, the leading online veterinary pharmacy and supplier of ...
Other Medicine News:Health News:SIS Offers Increased Financial and Operational Efficiencies with Pyxis Supply Technologies 2Health News:Econiche(TM) Vaccine Shows 92% Reduction in Colonization of E. coli O157 in Vaccinated Cattle 2Health News:Econiche(TM) Vaccine Shows 92% Reduction in Colonization of E. coli O157 in Vaccinated Cattle 3Health News:Econiche(TM) Vaccine Shows 92% Reduction in Colonization of E. coli O157 in Vaccinated Cattle 4Health News:Econiche(TM) Vaccine Shows 92% Reduction in Colonization of E. coli O157 in Vaccinated Cattle 5Health News:Econiche(TM) Vaccine Shows 92% Reduction in Colonization of E. coli O157 in Vaccinated Cattle 6Health News:Quantros Produces Video Detailing Enormous Problem of Preventable Medical Errors Plaguing The U.S. Healthcare System 2Health News:Quantros Produces Video Detailing Enormous Problem of Preventable Medical Errors Plaguing The U.S. Healthcare System 3Health News:Hawaii's Most Experienced and Only Fellowship-Trained Weight Loss Surgeon Now Coming to Hilo 2Health News:Hawaii's Most Experienced and Only Fellowship-Trained Weight Loss Surgeon Now Coming to Hilo 3Health News:Researchers discover ways of integrating treatment of traumatized Tibetan refugee monks 2Health News:Researchers discover ways of integrating treatment of traumatized Tibetan refugee monks 3Health News:PetCareRx Reinforces its Range of Arthritis and Joint Care Products for Winter 2
(Date:12/16/2009)... Inc. (Pink Sheets: AVXT) ("AVAX" or the "Company") ... loan financing (the "2009 Financing") pursuant to a ... with Firebird Global Master Fund, Ltd., ("Firebird"). Pursuant ... promissory note, due June 30, 2010, in the ... warrant to purchase an aggregate of 93,333,333 shares ...
(Date:12/16/2009)... NATICK, Mass., Dec. 16 Boston Scientific Corporation ... Company,s Board of Directors has elected Nelda Connors as ... President of the Electrical and Metal Products division of ... at Eaton Corporation, holding several positions in operations and ... employed in a number of executive and management capacities ...
(Date:12/16/2009)... According to Millennium Research Group (MRG), the global ... reforms in China supported rapid expansion of the ... continue to fuel growth in the coming years. ... Interventional Cardiology Devices 2010 report finds that ... the Chinese drug-eluting stent market to reach a ...
Breaking Medicine Technology:AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Stroke Damage Is Less in Rats Given Opioids 49194 1Keryx Biopharmaceuticals Inc Regains Compliance With NASDAQ Listing Requirements 49190 1Keryx Biopharmaceuticals Inc Regains Compliance With NASDAQ Listing Requirements 49190 2Keryx Biopharmaceuticals Inc Regains Compliance With NASDAQ Listing Requirements 49190 3Mylan Receives FDA Approval for Additional Strength of Generic Restoril 28R 29 49186 1
... Annual Meeting of EASLManagement to Discuss Study Results and ... P.M. EDT Today SAN DIEGO, April 23 Anadys ... that ANA598, the Company,s investigational non-nucleoside polymerase inhibitor, demonstrated ... well tolerated in a Phase Ib study in which ...
... SAFC Biosciences(R), a business segment within SAFC(R), a member of ... the introduction of EX-CELL(TM) EBx (R) cell growth and ... Euronext: VLS) EB66(R) duck cells used in the commercial ... EBx media is expected to further enable EB66 licensees ...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 2SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 3SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 4SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 5
... the durability of natural tissue ... of ingrowth and natural adaptation ... exceeds all applicable state and ... Tissue also reduces OR time ...
Meets the demanding requirements of most pelvic floor reconstructive procedures, and is highly resistant to suture pull-through, demonstrating long-term durability, and serves as a structural support...
... The FineTech-Brindley (also known as the ... which has been used by people with ... (or urinate) on demand. A secondary use ... bowel evacuation and promote penile erection.,The Bladder ...
... Nephrostomy Balloon is used to dilate the ... nephrostomy tract during a percutaneous procedure. The ... from the balloon to the catheter shaft ... close approximation of the dilating tract to ...
Medicine Products: